← Back to Search

Nerve Blocks for Hip Osteoarthritis (PENG Trial)

N/A
Waitlist Available
Led By Ronald Delanois, MD
Research Sponsored by LifeBridge Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up surgery to 1 month post surgery
Awards & highlights

PENG Trial Summary

This trial found that the pericapsular nerve block is more effective than the fascia iliaca nerve block for managing postoperative pain after total hip arthroplasty.

Eligible Conditions
  • Hip Osteoarthritis
  • Hip Arthritis

PENG Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~surgery to 1 month post surgery
This trial's timeline: 3 weeks for screening, Varies for treatment, and surgery to 1 month post surgery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Visual Analog Pain Scale (VAS) Score
Postoperative Opioid Consumption in mg
Secondary outcome measures
12 Item Short Form Health Survey Version 2
Distance upon first ambulation
Harris Hip Score
+3 more

PENG Trial Design

2Treatment groups
Active Control
Group I: Fascia Iliaca Nerve Block GroupActive Control1 Intervention
Fascia Iliaca Nerve Block targets the space between the iliacus muscle and the fascia that overlies it (fascia iliaca), within which the femoral nerve and lateral femoral cutaneous nerve (LFCN) course.
Group II: Pericapsular Nerve Block GroupActive Control1 Intervention
Pericapsular Nerve Block targets the anterior hip capsule by blocking the articular branches of the femoral nerve and accessory obturator nerve.

Find a Location

Who is running the clinical trial?

LifeBridge HealthLead Sponsor
28 Previous Clinical Trials
4,290 Total Patients Enrolled
Rubin Institute for Advanced OrthopedicsUNKNOWN
1 Previous Clinical Trials
100 Total Patients Enrolled
Ronald Delanois, MDPrincipal InvestigatorLifeBridge Health
2 Previous Clinical Trials
830 Total Patients Enrolled

Media Library

Fascia Iliaca Nerve Block Clinical Trial Eligibility Overview. Trial Name: NCT04729686 — N/A
Hip Osteoarthritis Research Study Groups: Fascia Iliaca Nerve Block Group, Pericapsular Nerve Block Group
Hip Osteoarthritis Clinical Trial 2023: Fascia Iliaca Nerve Block Highlights & Side Effects. Trial Name: NCT04729686 — N/A
Fascia Iliaca Nerve Block 2023 Treatment Timeline for Medical Study. Trial Name: NCT04729686 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What characteristics make a person an ideal candidate for this trial?

"The prerequisites to take part in this experiment are joint afflictions and ages between 18-80. 78 participants must be enrolled for the trial to begin."

Answered by AI

How many people can participate in this research project?

"Affirmative. Information found on clinicaltrials.gov reveals that this trial is actively recruiting participants, with the first posting being made on December 9th 2020 and its most recent edit occuring on April 14th 2022. The study requires 78 patients across one medical site to take part in it."

Answered by AI

Are individuals who are 40 years of age or older being accepted into this research project?

"According to the eligibility prerequisites, individuals aged 18-80 are qualified for participation in this clinical trial."

Answered by AI

Are there still opportunities for people to participate in this clinical research?

"Affirmative. According to clinicaltrials.gov, this study is still open for enrollment and was first posted on December 9th 2020 with the most recent update being published April 14th 2022. 78 patients need to be recruited from 1 medical centre."

Answered by AI
~18 spots leftby Apr 2025